(B) | 1. | ¯f¤H¨k©Ê68·³¡A¦]¥ý¦³«æ©Ê¯Ýµh¡A«áµo§@»´«×©I§l§xÃø¡A¸g¹L28¤p®É«á¡A¤~´MÂå¦í°|ªvÀø¡C²z¾ÇÀˬdµo²{«æ¯fª¬¡A¦åÀ£108/74
mmHg¡B¤ß¸õ108
/min¡B¤£³W«h¡BÀVÀR¯ß«ã±i¡B¤ßŦÂX¤j¡B¦³S3¡B¤ß¦y³¡¦³Gr.II/VI¤ßÁY©Ê¤ßŦÂøµ¡A¥ª«á¯Ý¤U³¡¦³ÀãÅoµ¤Î¸}³¡¤ô¸~¡A¤ß¹q¹Ï§e²{¨å«¬«e¾À¤ß¦Ù±ð¶ëÅܤơC¨Ì¾Ú¹êÃÒÂå¾Çþ¨ÇÃĪ«¾A¦X¥»¯f¤HªA¥Î¡Ha.ÀR¯ßª`®gtPA¡A¥ýµ¹¤©©Ó¸ü¡]loading¡^¾¯¶q15
mg¡A«e¥b¤p®É50 mg¡AÀH«á¤@¤p®É35 mgb. Aspirin 80 mg QDc. Metoprolol 50 mg QDd. Captopril 12.5 mg BIDe. Nifedipine 10 mg TID |
A. | a+b+c |
B. | b+c+d |
C. | c+d+e |
D. | a+c |
E. | b+d |
|
(C) | 2. | ¨å«¬ªºÄY«¥D°Ê¯ß佤³¬Âꤣ¥þ(Aortic valvular regurgitation)Å¥¶E¤£¥]¬A: |
A. | A high -pitched, blowing, decrescendo diastolic murmur at left lower sternal border |
B. | A mid-diastolic rumbling murmur at apex |
C. | An open snap |
D. | A systolic ejection murmur |
E. | An S4 gallop |
|
(D) | 3. | ÂX¤j¤ß¦Ù¯f(Dilated cardiomyopathy)¬OºØ«ùÄò´c¤Æ¯fµ{ªº¤ßŦ¯f¡A±`¦³¦å®ê®ê¶ë¡B¤ß«ß¤£¾ã¤ÎÖ`¦ºªºµo¥Í¡C¦³Ãöªº¦X²zÁ{§É³B¸m¦³¡Ga.±o¨Ï¥Î§Q§¿¾¯¡BACE inhibitors¡B£]-adrenergic blockers¤Îdigoxinb.À³¨Ï¥Î§Ü¤£¾ã¯ßÃĪ«¹w¨¾¤ß«ß¤£¾ã¤§µo¥Íc.À³§Ù°s¤ÎµÒd.©Ò¦³¯f¤HÀ³¦³¤ß¦Ù¤Á¤ù½T©w¶EÂ_¥H¬°¥ÎÃĤ§°Ñ¦Òe.¤ßŦ²¾´Ó¬O°ß¤@ªº¿ï¾Ü¡C |
A. | a+b+c |
B. | b+c+d |
C. | c+d+e |
D. | a+c |
E. | b+d |
|
(C) | 4. | ¯f¤H¬O38·³¤¤¾Ç¤k©Ê¦Ñ®v¡A¨â¦~«e¶}©l¹B°Ê©Ê©I§l§xÃø¡A·í®É¦³²Ä¤GLÃh¥¥¦b¨¡A¥Í²£«á¨Ã¥¼¦³§ïµ½¡A¤Ï¦Ó³vº¥¥[«¡A³Ìªñ¼Æ¶g¥un¤W¼Ó±è¤@¼h´N®ð«P¬Æ«æ¡A¤]¶¡©Î¦³©ü³Öªºµo¥Í¡A¤D¦í°|¶EÀø¡C²z¾ÇÀˬd¡G¦åÀ£140/95
mmHg¡BT/P/R¡G36.5¢J/84/20¡FÀVÀR¯ß¥¼¨£«ã±i¡F¤ß«ß³W«h¡B¥iIJı¥k¤ß«ÇÂX¤j¡B¦b¥ª¤U¯Ý½t¦³GrII/IV systolic
murmur¡BS1¥¿±`¡BP2¥[«¡B¥¼¦³S3¤ÎS4¡A¥¼¦³¨x¸~¤Î¸}¤ô¸~¡BªSª¬«ü(clubbing fingers)©ÎµoÖæ¡C¯Ý³¡X¥ú¦p¹Ï4
¤Î¤ß¹q¹Ï ¦p¹Ï¥Ü¡C³o¦ì¯f¤H³Ì¥¿½Tªº¤ßŦ¶EÂ_¬O |
A. | Postpartum cardiomyopathy |
B. |
Mitral stenosis |
C. |
Pulmonary arterial hypertension |
D. |
Aortic valvular stenosis |
E. |
Obstructive hypertrophic cardiomyopathy |
|
(D) |
5. |
©Ó¤WÃD¡A¥»¯f¨Ò¤§¶EÂ_®Ú¾Ú¦b©ó¡Ga.¯fª¬»PÃh¥¥¯f¥v¦³Ãöb.¥ª¤ß«ÇªÎ«pc.¥k¤ßÂX¤jd.¥ª¤ßŦ°IºÜe. °ª¦åÀ£ |
A. |
a+b+c |
B. |
b+c+d |
C. |
c+d+e |
D. |
a+c |
E. |
b+d |
|
(B) |
6. | ¤U¦C¦óªÌ¬O¤£¥¿½TªºÃöÁp |
A. | Ebstein·î§Î-¥k¤ß«ÇÂX¤j |
B. | Lutembacher's¯gÔ¸s-¥ª¤ß«ÇÂX¤j |
C. | Fallot¤ó¥|¦X¯g-ªÍ°Ê¯ß°ª¦åÀ£ |
D. | Sinus Valsalva¯}µõ-«ùÄò©Ê¤ßŦÂøµ |
E. | Marfan¯gÔ¸s-¥D°Ê¯ßÄuÂX¤j |
|
(C) |
7. |
¯f¤H26·³¡A¨k©Ê¡A©yÄõÀY«°¤u¤H¡A¥D¶D°¸¦³¯Ý´e¾ú¸g¤@Ó¤ë¡A¥L¦Û¤p¶}©l´N¤£¾A¹B°Ê¡A¯Ý¤f®É¦³ÄÁÂ\¼@°Ê¡A³Ìªñ±`¦³¹B°Ê¬ÛÃöªº¯Ý´e¡A
¦ñ¦³¤ß±ª·w¯t¡A¦³®É±j«×¹B°Ê·|¦³µoÖæ¡C¬J©¹¯f¥v¥¼¦³¯S§O¡C²z¾ÇÀˬd¡G¨°ª155cm¡BÅé«45.5kg¡B¦åÀ£108/70mmHg¡B¤ß¸õ80/min¡BÀVÀR¯ß¥¿±`¡BPMI¥ª5th
ICS(intercostal space)ªºLMCL(left middle clavicular line)¡BRV
heave¡B¦b¥ª¤W¯Ý½t¦³Gr. III/VI systolic ejection murmur with fixed splitting
S2¡A¥¼¦³¤ßÂøµ¶Ç²¾¡AP2¥[«¡C¨ä¥L²z¾ÇÀˬd¥¼¦³¤£¥¿±`¡A¯Ý³¡X¥ú¦p
¹Ï7¡A
¤ß¹q¹Ï¦p¹Ï¡C¥»¯f¤H°µ¥¿½Tªº¤ßŦ¶EÂ_¬O¡G |
A. |
Pulmonary stenosis |
B. |
Idiopathic pulmonary hypertension |
C. |
Atrial septal defect |
D. |
Aortic stenosis |
E. |
Mitral stenosis |
|
(C) |
8. |
¯f¤H53·³¡A¨k©Ê¡A¦]¦³¤@Ӥ몺¯Ý´e¨ìªù¶E¨Dªv¡A¯Ý´e·|¦³¥ª¤U¤Úµo³Â¡A»P¹B°Ê¬ÛÃö¡A¨C¦¸µo§@3¦Ü5¤ÀÄÁ¡A¥ð®§¥i½w¸Ñ¡C¯f¥v¥]¬A°ª¯×¦å¥b¦~¤Î
©â·Ï30¦~¡A¦ý¤w§ÙµÒ¡C²z¾ÇÀˬd¡G¦åÀ£145/96mmHg¡B¤ß¸õ80/min¡B¨ä¥LÀˬd©|µL¤£¥¿±`¡C¤ß¹q¹Ï¦p¹Ï
8-1¡B
8-2¡A
¥Í¤Æ¡Gsugar(AC/PC)95/141 mg/dl¡Btotal cholesterol 191 mg/dl¡BHDL-C 29 mg/dl¡BLDL-C 104 mg/dl¡Btriglyceride 289 mg/dl¡BAST 27U/L¡BALT 45 U/L¡B
creatinine 1.2 mg/dl¡Buric acid 9.2 mg/dl¡C«ö·Ó¹êÃÒÂå¾Ç¤Î§Ú°ê°·«O¤§³W©w¡A¤U¦C¦óªÌ³B¸m¬O¥¿½Tªº |
A. |
¥»¯f¤HÀ³µ¹¤©«DÃĪ«ªvÀø(¶¼¹¡B¹B°Ê¡B§ÙµÒ°sµ¥¥Í¬¡ÁB¥¿)¤T¦Ü¤»Ó¤ë¡A¤~¥i¨Ï¥Îfenofibrate (Lipanthyl)100 mg QD |
B. |
°¦å¯×ÃĪ«ªºªvÀø¥Ø¼Ð¦btriglyceride < 200 mg/dl¡Bcholesterol < 160 mg/dl |
C. |
¥i§Y¨è°_¨BªvÀø°ª¦åÀ£¨Ã³]©wsystolic¤Îdiastolic
BPªvÀø¥Ø¼Ð¤À§O¦b<140 mmHg ¤Î90 mmHg |
D. |
¨Ì§Ú°ê°·«O³W©w¡A³o¦ì¯f¤Hªº°¦åÀ£¥H³æ¤èªvÀø(monotherapy)¬°©y |
E. |
¨Ì¬ü°êJNC-7¡A¥»¯f¤H³Ì¦X¾Aªº°_¨BªvÀø¬O£\-adrenergic receptor blocker |
|
(A) |
9. |
¯f¤H69·³¨k©Ê¡A¤T¤Ñ«e¦³¥b¤p®É¯Ýµh¡A»P¹B°ÊµLÃö¡AÀH«á¦³Âù°¼¤ô¸~¡A¤£¦A¦³¯Ýµh¡A¤D¨ìªù¶E¨DÂå¡A«áÂà°e«æ¶E¦¬ªv¡C¯f¥v¦³¿}§¿¯f6-7¦~¥~¡A
µL¨ä¥L¦MÀI¦]¯À¡C²z¾Ç¡G¦åÀ£139/79mmHg¡B¤ß¸õ78/min¡B©I§l20/min¡C¥¼¦³ÀVÀR¯ß«ã±i¡AªÍ³¡¦³»´«×ÀãÅoµ¡A¤ßŦ·LÂX¤j¡B¤ß¦y³¡¦³S4¤ÎGr II/VI systolic murmur¡B
Âù¤p»L¤ô¸~¡A¨ä¥L¨ÃµL¤£¥¿±`¡C
¤ß¹q¹Ï
¦p¹Ï¡ACK/CKMB/TnI: 456 U/L/53. 1U/L/12.1U/L; sugar 153mg/dl¡Bcreatinin 2.5 mg/dl¡Btriglyceride 109 mg/dl¡Bcholesterol 145 mg/dl¡C¥»¯f¤H¤U¦C¦ó
ªÌªº³B¸m¤£²Å¦X¹êÃÒÂå¾Ç¡G |
A. | ³w¥ÎtPA 15 mg ©Ó¸ü¾¯¶q(lodading dose)ÀRª`¡A45 mg/¥b¤p®É¤§
«á30 mg¤@¤p®É©MHeparin 3000uÀRª`¤Î10000u¦b500cc normal saline/24¤p®ÉÀRª` |
B. | Nitroglycerin 50 mg in 125 cc dextrose / salineÀR¯ßª`®g |
C. | ªA¥ÎGliquidone 30 mg BIDªvÀø¿}§¿¯f |
D. | ¥X°|«e¸g¥Ö«aª¬°Ê¯ß¦¨§Î³N³B¸m |
E. | Aspirin 80 mg |
|
(A) | 10. | ¨S¦³¹êÃÒÂå¾Ç®Ú¾Ú¡A¤£«Øij¿ï¥Î¾ÉºÞ¿N¨`¤â³N(Catheter ablation)ªº¤ß«ß¤£¾ã¬°: |
A. | Ventricular tachycardia in patient with coronary artery disease |
B. | Idiopathic ventricular tachycardia with LBBB configuration and superior axis |
C. | Recurrent cavotricuspid isthmus atrial flutter |
D. | WPW syndrome with posteroseptal right atrium Kent tract |
E. | Atrioventricular nodal tachycardia |
|
(C) | 11. | ¤U¦C¦³Ãö¥D°Ê¯ßéÂ÷(Aortic dissection)ªº»¡ªk¬O¤£¥¿½Tªº: |
A. | ¥»¯f¬O¤T¯ÅÂåÀø³æ¦ìªº¤ßŦ«æ¯g |
B. | B«¬¥D°Ê¯ßéÂ÷¦ñ¦³«æ©ÊµÇŦ°IºÜ¤´¥H¤º¬ìÀøªk¬°©y |
C. | ¼h¤º¦å¶ô(Intramural hematoma)¥¼¦ñ¦³¥D°Ê¯ß¤º¼h(Intimal rupture)¯}µõ¡A¤£¦Ü©óµo¥Í¤ß¥]½¤¥R¶ñ¤Î§C¦åÀ£¤´¥H¤º¬ìªvÀø¬°©y |
D. | ¤£«Ý¹q¸£Â_¼h¼v¹³¡A¥H¹¹D¶Wµªi¶EÂ_²ÄI«¬¥D°Ê¯ßéÂ÷´N¥i³w°e¥~¬ìªvÀø |
E. | ¥HÀRª`labetalol 50 mg/10 min½Õ±±¦¬ÁYÀ£¦b100-120 mmHg¬O°_¨BªºªvÀø¥Ø¼Ð |
|
(B) | 12. | ¥H¤U°t¹ï¦óªÌ¬°¤£¥¿½T¡H |
A. | ¯ß·i§¹¥þ¤£³W«h(irregularly irregular)¥B¨ä¤j¤p¤£¤@--¥ª¤ß©ÐÅÖºûŸ°Ê(atrial fibrillation) |
B. | ÂÛ¸õ¯ß(bounding pulse)--¦åÀ£130/82 mmHg |
C. | ¯ß·i³W«h¦ý±j®z¤@¤j¤@¤p¥æ´ÀÅÜ°Ê--¥ª¤ß«Ç®g¥X²v(ejection fraction)20% |
D. | ¥¿±`©I§lª¬ºA¤U¡A¦b§l®ð®É¯ß·i©úÅãÅÜ®z©Î®ø¥¢--¤ß¥]Ån¶ñ¶ë(cardiac tamponade) |
E. | ¤ß³t²v¤j©ó¾ø°©°Ê¯ß(radial artery)¯ß·i³t²v--¯ß·iµu²Ò(pulse deficit) |
|
(A) | 13. | ¦³Ãö¤ßŦÂH²G½F(myxoma)¡A¤U¦C¦óªÌ¬°«D¡H |
A. | ¤ßŦÂH²G½F¬°¤ßŦ³Ì±`¨£¤§ìµo©Ê´c©Ê(¯f²z¤W)¸~½F |
B. | ¯f¤H¥i¯à¥HªÍÆ{¦å¡A°Ê¯ß®ê¶ë¡Aµo¿N¡A©ü³Ö¡AÖ`¦ºµ¥ªí²{ |
C. | ¤ßŦť¶E¡AÂøµ¥i¯à¦]Åé¦ì§ïÅܦӦ³©ÒÅÜ¤Æ |
D. | ¤ßŦ¶Wµªi¬°³Ì¦nªº¶EÂ_¤u¨ã |
E. | ¶EÂ_«á¤@¯ë¤£°µ¾ÉºÞ¡AÀ³§Y®É¶}¤M |
|
(D) | 14. | ¦³Ãö«æ©Ê¥k¤ß«Ç¤ß¦Ù±ð¶ë¤§±Ôz¡A¦bA-E¤§²Õ¦X¤¤¡A¦óªÌ¬°¥¿½T¡Ha.³q±`»P¤U¾À¤ß¦Ù±ð¶ë¦X¨Öµo¥Í¡A¤ß¹q¹Ï¤SÅã¥Ü¦bV3R©ÎV4R¾Éµ{¤§ST¬q¤W¤Éb.±`¦X¨Ö§C¦åÀ£¡A°ªÀVÀR¯ßÀ£¡A¦]¦¹À³»P¤ß¥]Ån¶ñ¶ë°µÅ²§O¶EÂ_c.³q±`ªÍ°Ê¯ß·¤À£³q±`¥¿±`©Îµy·L¤W¤Éd.ÀR¯ß¸É¥R²GÅé¥i´£°ª¦åÀ£e.µ¹¤©§Q§¿¾¯¤Îµv»ÄÆQ(nitrates)¥i§ïµ½¯f±¡ |
A. | a+b+e |
B. | b+d+e |
C. | b+c+d |
D. | a+b+c+d |
E. | a+b+c+d+e |
|
(E) | 15. | ¹ï¥D°Ê¯ßäÄY«¯U¯¶»Pªý¶ë©ÊªÎ«p©Ê¤ß¦Ù¯f¨âªÌ¤§±Ôz¡A¦óªÌ¬°¤£¥¿½T |
A. | ¨âªÌ¦³¬Û¦ü¤§Á{§Éªí²{¡A¥]¬A©I§l§xÃø¡A¯U¤ß¯g¡A©ü³Ö¤ÎÖ`¦º |
B. | ¦b¥D°Ê¯ßäÄY«¯U¯¶¡AÀV°Ê¯ß·i°ÊÅã¥Ü©µ¿ð¤W³»(slow upstroke) |
C. | ¨âªÌ¤ß¹q¹Ï¬ÒÅã¥Ü¥ª¤ß«ÇªÎ¤j |
D. | ¦bªý¶ë©ÊªÎ«p¤ß¦Ù¯f¡A¦¬ÁY´ÁÂøµ¦b°µValsalva°Ê§@¤Î¯¸¥ß®ÉÅܤj¡AÃÛ¤U®ÉÅܤp |
E. | ¦b¤ß°IºÜ®É¨âªÌ¬Ò¥i¨Ï¥ÎdigoxinªvÀø |
|
(E) | 16. | ¤@¦W35·³±w¦³¤G¦yä¯U¯¶¤§¤k©Ê¡A¦]ÄY«©I§l§xÃø©ó«æ¶E«Ç¨D¶E¡A²z¾ÇÀˬdµo²{¯f¤HºÝ§¤©I§l¡A·NÃÑ©|ÄݲM´·¡A¤â¸}¦B§N¡A¦³µoÖæ²{¶H¡A¦åÀ£92/70mmHg¡A¤ß³t²v¨C¤ÀÄÁ160§¹¥þ¤£³W«h(irregularly irregular)¡A¤ßŦÀˬd¯Ý°©¥ª½t¦³¦¬ÁY´Á·i°_(parasternal lift)¡A²Ä¤@¤Î²Ä¤G¤ßµ¤®¶i¡AÅ¥¤£¨ìÂøµ¡AªÍ³¡¦³Äjº©©ÊÅoµ¡A¤ß¹q¹ÏÅã¥Ü¤ß©ÐÅÖºûŸ°Ê(atrial fibrillation)¡A°£¤F¨Ñ»P®ñ®ð¥~¡A³Ì¾A·í¤§¥ß§Y³B¸m¬° |
A. | ÀR¯ßª`®gdigoxin |
B. | ÀR¯ßª`®gdopamine¤Î§Q§¿¾¯ |
C. | ÀR¯ßª`®gverapamil |
D. | ÀR¯ßª`®gamiodarone |
E. | ¹qÀ»(electrical cardioversion) |
|
(B) |
17. |
¤WÃD¯f¤H¸g¤Wz³B¸m«á¡A¤ß¸õÅܬ°³W«h(³t²v¨C¤ÀÄÁ90)«á¡A©úÅãÅ¥¨ìopening snap¤ÎµÎ±i´ÁÂøµ¡A¦åÀ£¦^¤É¦Ü112/78 mmHg¡AÀVÀR¯ßÀ£©úÅã¤W¤É
¬ù16 cm H2O¡AÀVÀR¯ßªiaªi¡A¸g¯Ý«e¤ßŦ¶WµªiÀˬdÃÒ¹ê¯f¤H¦³ÄY«¤G¦yä¯U¯¶¡A¥H§Q§¿¾¯ªvÀø«áªÍ¥R¦å(pulmonary venous congestion)§ïµ½¡A¸g¹¹D¤ßŦ¶WµªiÀˬd½T
»{¥ª¤ß©Ð¤ºµL¦å®ê«á¬I¦æ®ð²y¾ÉºÞ¤G¦yäÂX±i³N¦¨¥\¡A¤U¦C±Ôz¦óªÌ¬°«D¡H |
A. |
¤G¦yäÂX±i³N«e¤ß¾ÉºÞÀˬd¹w´Á©Ò¨£¬°¥k¤ß©Ð¡AªÍ°Ê¯ß·¤À£(wedge pressure)²§±`¤W¤É |
B. |
³N«áA2-opening snap¶¡¹jÅܵu |
C. |
µÎ±i´ÁÂøµÅܵu©Î®ø¥¢ |
D. |
²Ä¤@¤ßµ¤®¶i¤£ÅÜ |
E. | ¥H¤W¬Ò¥¿½T |
|
(C) |
18. |
¤@¦W60·³¤k©Ê¬°¿}§¿¯f¯f±w¡A¨ä°ª¦å¯×¯g¸g¤TÓ¤ë«DÃĪ«ªvÀø«á¡AÁ`Áx©T¾J(TC)¬°198 mg/dl¡A§C±K«×¯×³J¥ÕÁx©T¾J(LDL-C)¬°110 mg/dl¡A
°ª±K«×¯×³J¥ÕÁx©T¾J(HDL-C)¬°38 mg/dl¡A¤¤©Ê¯×ªÕtriglycerides(TG)¬°250 mg/dl¡A¥H¤U±Ôz¦óªÌ¤£¥¿½T¡H |
A. |
¦¹¯f±wÁöµL«aª¬°Ê¯ß¯e¯f¤§¯gª¬(¦p¯U¤ß¯g¡A¤ß¦Ù±ð¶ë)¡A¦ýÀ³³Qµø¬°µ¥¦P¦³«aª¬°Ê¯ß¯e¯f(CAD equivalent) |
B. |
¦¹¯f±w²Å¦X°·«O°¦å¯×¯gÃĪ«³W½d¡A¥iµ¹¤©§Ü¦å¯×ÃĪ«ªvÀø(À³¦P®Éµ¹¤©«DÃĪ«ªvÀø) |
C. |
¦p²Å¦X°·«O³W½d¡Astatin¡Afibrates¡Aniacin¤Îcholestyramineµ¥ÃĪ«¤¤¡A¦b¦¹¯f±w¤§º¿ïÃĪ«¬°statin |
D. |
ÃĪ«ªvÀø¥Ø¼Ð¬°Á`Áx©T¾JTC <160 mg/dl¡ALDL-C ¡Ø100 mg/dl¤ÎTG <150 mg/dl |
E. | (ªÅ¥Õ) |
|
(D) |
19. | ¤U¦C¥i¯à¾ÉP§C¦åÀ£©Î¥ð§J¤§«æ¶E¤¤¡A¦óªÌ³Ì®e©ö¶EÂ_¤ÎªvÀø |
A. | §C®e©Ê¥ð§J(hypovolemic shock) |
B. | ¤ß¥]Ån¶ñ¶ë(cardiac tamponade)¾ÉP¤§ªý¶ë©Ê¥ð§J(obstructive shock) |
C. | ªÍ°Ê¯ß®ê¶ë(pulmonary embolism)¾ÉP¤§ªý¶ë©Ê¥ð§J |
D. | ±i¤O©Ê®ð¯Ý(tension pneumothorax)¾ÉP¤§ªý¶ë©Ê¥ð§J |
E. | «æ©Ê¤ß¦Ù±ð¶ë¾ÉP¤§¤ß¦]©Ê¥ð§J(cardiogenic shock) |
|
(D) | 20. | ¯Ý³¡X¥úÀˬd²§©ó¨ä¥L³¡¦ì¤§X¥úÀˬd¡A¥ç¥i¶¡±µµû¦ôªÍ´`Àô¨t²Î¦å¦æ°Ê¤O¾Ç(hemodynamics)¤§ª¬ºA¡A¤U¦C(a)-(d)¤§¦å¦æ°Ê¤O¾Ç©Ò¨£¤§A-E²Õ¦X¤¤¡A¨ä¥i¥¿½T¶¡±µµû¦ô(©w©Ê©Î¥b©w¶q)©Ò¨£¤§²Õ¦X¬°¦óªÌ(a)ªÍÀR¯ßÀ£¤ÎªÍ°Ê¯ß·¤À£(wedge pressure)(b)ªÍ°Ê¯ßÀ£(c)¥k¤ß«ÇµÎ±i´ÁÀ£(d)ªÍ¦å¬y¶q(¦p¦b¤ß©Ð¤¤¹j¯Ê·lµ¥¤ßŦ¥ª¥k¤À¬y¡Aleft - to- right shunt) |
A. | a+b |
B. | a+b+c |
C. | b+c |
D. | a+b+d |
E. | a+b+c+d |
|
(B) | 21. | ¤@¦W60·³¨k©Ê¡A¦]ÄY«©I§l§xÃø¦Ü«æ¶E«Ç¨D¶E¡A²z¾ÇÀˬdµo²{¯f¤H¥bºÝ§¤©I§l¡A·NÃÑ©|²M´·¡A¦åÀ£100/70
mmHg¡A¤ß³t²v100/min³W«h¡A¤â¸}¦B§N¦Ó¦³»´·LµoÖæ²{¶H¦ýµL¯B¸~¡BÀVÀR¯ßÀ£¥¿±`¡B¤ßŦ¥ª¤ß«ÇÂX¤j¡B²Ä¤G¤ßµ(P2)¤®¶i¡BµLÂøµ¦ý¦³²Ä¥|¤ßµ(S4)¡BªÍ³¡¦³Äjº©©ÊÅoµ¡C¤ß¹q¹ÏÅã¥ÜÄu©Ð«ß(sinus rhythm)¤Î«D¯S²§©ÊSTTÅܤơA¯Ý³¡X¥ú¦³«æ©ÊªÍ¤ô¸~(pulmonary edema)¤Î¤ßŦÂX¤j¤§©Ò¨£¡A¤ßŦ¶WµªiÀˬd¥ª¤ß«ÇÂX¤j¤Î¥ª¤ß«Ç®g¥X²v(ejection fraction)25%¡A¦¹¯f±w¸g¨Ï¥Îdopamine¡Bfurosemide¡Baldactone¡Bµv»ÄÆQ(nitrates)¡BACEI(angiotensin converting enzyme inhibitor)¤Î¤ò¦a¶ÀdigoxinªvÀø«áªÍ¤ô¸~©úÅã§ïµ½¡C¦b¦³Ãö¦¹¯f¤H¥i¨Ï¥Î¤§¤U¦CÃĪ«(a)-(d)¤§±Ôz¡A¨äA-E²Õ¦X¡A¦óªÌ¬°¥¿½T¡H(a)¨Ï¥Îµv»ÄÆQ¡B¤ò¦a¶À¤Î§Q§¿¾¯¥i§ïµ½¦¹¯f¤Hªø´Á¹w«á(b)ACEI©ÎARB (angiotensin receptor blocker)¥i§ïµ½¦¹¯f¤Hªø´Á¹w«á(c)¨Ï¥Îaldactone¥i§ïµ½¦¹¯f¤Hªø´Á¹w«á(d)¨Ï¥Î¤A«¬¥æ·P¯«¸gªýÂ_¾¯(beta-blocker)¥i§ïµ½¦¹¯f¤Hªø´Á¹w«á¡A¦]¦¹·í¯f¤Hè¨ìÂå°|¯f±¡¥¼Ã©w®É¡A§YÀ³¨Ï¥Î¦¹ÃÄ |
A. | a+c |
B. | b+c |
C. | b+d |
D. | a+b+c |
E. | a+b+c+d |
|
(D) | 22. | ±N¹ï°ª¦åÀ£¯f¤H¥HÃĪ«ªvÀø¡A¦p¦³¤U¦C¨ä¥¦¦X¨Ö¯g®É¡A¨äº¿ïÃĪ«»P¨ä¦X¨Ö¯g¤§¥H¤U°t¹ï¡A¦óªÌ¤£¾A·í¡H |
A. | ¿}§¿¯fµÇ¯fÅÜ¡A³J¥Õ§¿--Âà¤ÆúC§í¨î¾¯(ACEI)©ÎARB(angiotensin receptor 1 blocker) |
B. | ÄáÅ@¸¢ªÎ¤j¡A±Æ§¿§xÃø--¥Ò«¬¥æ·P¯«¸g§í¨î¾¯(alpha-blocker) |
C. | ¯U¤ß¯g--¤A«¬¥æ·P¯«¸gªýÂ_¾¯(beta-blocker) |
D. | ¤ß©ÐŸ°Ê(atrial fibrillation)¡A¤ß«Ç³t²v¨C¤ÀÄÁ120--dihydropiridinesÃþ¶tÂ÷¤lªýÂ_¾¯(¦pnifedipine, amlodipine) |
E. | ¥H¤W¬Ò¾A·í |
|